Development of Molecular Pharmacodynamic Assays for Targeted Therapies

Information

• Research Project
• 7945131

• ApplicationId

  7945131

• Core Project Number

  261200900069C-0-0-1

• Full Project Number

  261200900069C-0-0-1

• Serial Number

  0

• FOA Number

• Sub Project Id

• Project Start Date

  9/30/2009 - 16 years ago

• Project End Date

  3/31/2010 - 15 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2009

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• SINGULEX, INC

During the Phase I portion of this contract Singulex will develop Erenna assays for human EGFR, MMP[unreadable]2, TIMP2, and MMp[unreadable]2rr1MP-2 complex. We will carry out preliminary validation of these assays and demonstrate feasibility of these assays for measuring the target analytes in human tissues.

IC Name

• Activity

  N43

• Administering IC

  CA

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  149760

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  395

• Ed Inst. Type

• Funding ICs

  NCI:149760\

• Funding Mechanism

  Contracts, Extramural

• Study Section

• Study Section Name

• Organization Name

  SINGULEX, INC.

• Organization Department

• Organization DUNS

  946338688

• Organization City

  ALAMEDA

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  94502

• Organization District

  UNITED STATES